Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


14.01.2019

1 Acta Ophthalmol
1 Am J Cardiol
1 Am J Clin Nutr
1 Am J Hypertens
2 Am J Manag Care
1 Am J Med
1 Atheroscler Suppl
1 Circulation
4 Diabet Med
3 Diabetes
1 Diabetes Care
15 Diabetes Obes Metab
15 Diabetologia
1 Hypertension
1 Invest Ophthalmol Vis Sci
3 J Clin Endocrinol Metab
1 J Diabetes Complications
1 J Hypertens
1 J Nutr
2 JAMA
1 Lancet
1 Metabolism
1 Nutr Metab (Lond)
1 Obstet Gynecol
1 Pediatr Diabetes
7 PLoS One
1 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. DANNI R, Viljanen A, Aaronson A, Tuuminen R, et al
    Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
    Acta Ophthalmol. 2019 Jan 8. doi: 10.1111/aos.14018.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. HUYNH T, Harty BJ, Claggett B, Fleg JL, et al
    Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin+Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study).
    Am J Cardiol. 2018 Nov 24. pii: S0002-9149(18)32103.
    PubMed     Text format     Abstract available


    Am J Clin Nutr

  3. LIND MV, Lauritzen L, Kristensen M, Ross AB, et al
    Effect of folate supplementation on insulin sensitivity and type 2 diabetes: a meta-analysis of randomized controlled trials.
    Am J Clin Nutr. 2019 Jan 5. pii: 5274479. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Hypertens

  4. LU J, Zhang S, Li W, Leng J, et al
    Maternal gestational diabetes is associated with offspring's hypertension.
    Am J Hypertens. 2019 Jan 9. pii: 5281125. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Manag Care

  5. GABBAY R
    A paradigm shift highlights the need to reduce CV risk in diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Text format    

  6. KIRSNER RS
    Clinical evidence for and cost-effectiveness of advanced cellular tissue products for the treatment of diabetic foot ulcers.
    Am J Manag Care. 2018;24.
    PubMed     Text format    


    Am J Med

  7. GUPTA S, Goyal P, Thumma S, Mattana J, et al
    Diabetic Mastopathy Masquerading as Breast Cancer.
    Am J Med. 2019 Jan 3. pii: S0002-9343(19)30003.
    PubMed     Text format    


    Atheroscler Suppl

  8. OLMASTRONI E, Shlyakhto EV, Konradi AO, Rotar OP, et al
    Epidemiology of cardiovascular risk factors in two population-based studies.
    Atheroscler Suppl. 2018;35:e14-e20.
    PubMed     Text format     Abstract available


    Circulation

  9. GREENE SJ, Butler J
    Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.
    Circulation. 2019;139:152-154.
    PubMed     Text format    


    Diabet Med

  10. GOFF LM
    Ethnicity and Type 2 diabetes in the UK.
    Diabet Med. 2019 Jan 6. doi: 10.1111/dme.13895.
    PubMed     Text format     Abstract available

  11. MUNCH L, Bennich BB, Overgaard D, Konradsen H, et al
    Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial.
    Diabet Med. 2019 Jan 6. doi: 10.1111/dme.13896.
    PubMed     Text format     Abstract available

  12. DHATARIYA KK, Parsekar K, Skedgel C, Datta V, et al
    The cost of treating diabetic ketoacidosis in an adolescent population in the UK: a national survey of hospital resource use.
    Diabet Med. 2019 Jan 6. doi: 10.1111/dme.13893.
    PubMed     Text format     Abstract available

  13. AJLOUNI K, Batieha A, Jaddou H, Khader Y, et al
    Time trends in diabetes mellitus in Jordan between 1994 and 2017.
    Diabet Med. 2019 Jan 6. doi: 10.1111/dme.13894.
    PubMed     Text format     Abstract available


    Diabetes

  14. SELVARAJAH D, Wilkinson ID, Fang F, Sankar A, et al
    Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study.
    Diabetes. 2019 Jan 7. pii: db18-0509. doi: 10.2337/db18-0509.
    PubMed     Text format     Abstract available

  15. VAN LUMMEL M, Buis DTP, Ringeling C, de Ru AH, et al
    Epitope Stealing as Mechanism of Dominant Protection by HLA-DQ6 in Type 1 Diabetes.
    Diabetes. 2019 Jan 9. pii: db18-0501. doi: 10.2337/db18-0501.
    PubMed     Text format    

  16. BLAIR PJ, Hwang SJ, Shonnard MC, Peri LE, et al
    The Role of Prostaglandins in Disrupted Gastric Motor Activity Associated with Type 2 Diabetes.
    Diabetes. 2019 Jan 9. pii: db18-1064. doi: 10.2337/db18-1064.
    PubMed     Text format     Abstract available


    Diabetes Care

  17. JOVANOVSKI E, Khayyat R, Zurbau A, Komishon A, et al
    Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Diabetes Care. 2019 Jan 7. pii: dc18-1126. doi: 10.2337/dc18-1126.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  18. JONES KL, Rigda RS, Buttfield MD, Hatzinikolas S, et al
    Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycemia in health and type 2 diabetes.
    Diabetes Obes Metab. 2019 Jan 9. doi: 10.1111/dom.13633.
    PubMed     Text format     Abstract available

  19. BORG MJ, Jones KL, Sun Z, Horowitz M, et al
    Metformin attenuates the postprandial fall in blood pressure in type 2 diabetes.
    Diabetes Obes Metab. 2019 Jan 7. doi: 10.1111/dom.13632.
    PubMed     Text format     Abstract available

  20. GALLO S, Charbonnel B, Goldman A, Shi H, et al
    Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.
    Diabetes Obes Metab. 2019 Jan 7. doi: 10.1111/dom.13631.
    PubMed     Text format     Abstract available

  21. NORHAMMAR A, Bodegard J, Nystrom T, Thuresson M, et al
    Dapagliflozin and Cardiovascular Mortality and Disease Outcomes in Type 2 Diabetes Patients Similar to the DECLARE-TIMI 58 Participants: A Nationwide Observational Study.
    Diabetes Obes Metab. 2019 Jan 4. doi: 10.1111/dom.13627.
    PubMed     Text format     Abstract available

  22. GIUGLIANO D, Meier JJ, Esposito K
    Heart failure and type 2 diabetes: From CVOTs, with hope.
    Diabetes Obes Metab. 2019 Jan 4. doi: 10.1111/dom.13629.
    PubMed     Text format     Abstract available

  23. FAN W, Song Y, Inzucchi SE, Sperling L, et al
    Composite Cardiovascular Risk Factor Target Achievement and its Predictors in US Adults with Diabetes: The Diabetes Collaborative Registry.
    Diabetes Obes Metab. 2019 Jan 4. doi: 10.1111/dom.13625.
    PubMed     Text format     Abstract available

  24. FRIAS JP, Zimmer Z, Lam RLH, Lic GA, et al
    Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin up-titration in treatment of patients with type 2 diabetes: the CompoSIT-M Study.
    Diabetes Obes Metab. 2019 Jan 4. doi: 10.1111/dom.13626.
    PubMed     Text format     Abstract available

  25. ALVELOS MI, Juan-Mateu J, Colli ML, Turatsinze JV, et al
    When one becomes many-Alternative splicing in beta-cell function and failure.
    Diabetes Obes Metab. 2018;20 Suppl 2:77-87.
    PubMed     Text format     Abstract available

  26. PETRENKO V, Philippe J, Dibner C
    Time zones of pancreatic islet metabolism.
    Diabetes Obes Metab. 2018;20 Suppl 2:116-126.
    PubMed     Text format     Abstract available

  27. THOMAIDOU S, Zaldumbide A, Roep BO
    Islet stress, degradation and autoimmunity.
    Diabetes Obes Metab. 2018;20 Suppl 2:88-94.
    PubMed     Text format     Abstract available

  28. WEI FY, Tomizawa K
    tRNA modifications and islet function.
    Diabetes Obes Metab. 2018;20 Suppl 2:20-27.
    PubMed     Text format     Abstract available

  29. ESGUERRA JLS, Nagao M, Ofori JK, Wendt A, et al
    MicroRNAs in islet hormone secretion.
    Diabetes Obes Metab. 2018;20 Suppl 2:11-19.
    PubMed     Text format     Abstract available

  30. NAPOLITANO T, Silvano S, Vieira A, Balaji S, et al
    Role of ghrelin in pancreatic development and function.
    Diabetes Obes Metab. 2018;20 Suppl 2:3-10.
    PubMed     Text format     Abstract available

  31. LIU M, Weiss MA, Arunagiri A, Yong J, et al
    Biosynthesis, structure, and folding of the insulin precursor protein.
    Diabetes Obes Metab. 2018;20 Suppl 2:28-50.
    PubMed     Text format     Abstract available

  32. MESZAROS G, Pasquier A, Vivot K, Goginashvili A, et al
    Lysosomes in nutrient signalling: A focus on pancreatic beta-cells.
    Diabetes Obes Metab. 2018;20 Suppl 2:104-115.
    PubMed     Text format     Abstract available


    Diabetologia

  33. KOLIBABKA M, Dietrich N, Klein T, Hammes HP, et al
    Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy.
    Diabetologia. 2018;61:2412-2421.
    PubMed     Text format     Abstract available

  34. LIN CY, Hsieh MC, Kor CT, Hsieh YP, et al
    Association and risk factors of chronic kidney disease and incident diabetes: a nationwide population-based cohort study.
    Diabetologia. 2019 Jan 3. pii: 10.1007/s00125-018-4788.
    PubMed     Text format     Abstract available

  35. HAJMOUSA G, Przybyt E, Pfister F, Paredes-Juarez GA, et al
    Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells.
    Diabetologia. 2018;61:2371-2385.
    PubMed     Text format     Abstract available

  36. NAHON KJ, Doornink F, Straat ME, Botani K, et al
    Effect of sitagliptin on energy metabolism and brown adipose tissue in overweight individuals with prediabetes: a randomised placebo-controlled trial.
    Diabetologia. 2018;61:2386-2397.
    PubMed     Text format     Abstract available

  37. IFIE E, Russell MA, Dhayal S, Leete P, et al
    Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells.
    Diabetologia. 2018;61:2344-2355.
    PubMed     Text format     Abstract available

  38. YU Y, Gamble A, Pawlick R, Pepper AR, et al
    Bioengineered human pseudoislets form efficiently from donated tissue, compare favourably with native islets in vitro and restore normoglycaemia in mice.
    Diabetologia. 2018;61:2016-2029.
    PubMed     Text format     Abstract available

  39. GROEN MB, Knudsen TA, Finsen SH, Pedersen BK, et al
    Reduced skeletal-muscle perfusion and impaired ATP release during hypoxia and exercise in individuals with type 2 diabetes.
    Diabetologia. 2019 Jan 3. pii: 10.1007/s00125-018-4790.
    PubMed     Text format     Abstract available

  40. RINGHOLM L, Roskjaer AB, Engberg S, Andersen HU, et al
    Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy.
    Diabetologia. 2019 Jan 3. pii: 10.1007/s00125-018-4794.
    PubMed     Text format     Abstract available

  41. THOMAS AA, Biswas S, Feng B, Chen S, et al
    lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy.
    Diabetologia. 2019 Jan 5. pii: 10.1007/s00125-018-4797.
    PubMed     Text format     Abstract available

  42. CHATENOUD L
    A future for CD3 antibodies in immunotherapy of type 1 diabetes.
    Diabetologia. 2019 Jan 5. pii: 10.1007/s00125-018-4808.
    PubMed     Text format    

  43. THIVOLET C, Marchand L, Chikh K
    Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
    Diabetologia. 2019 Jan 6. pii: 10.1007/s00125-018-4804.
    PubMed     Text format     Abstract available

  44. YANG J, Chen C, McLaughlin T, Wang Y, et al
    Loss of X-box binding protein 1 in Muller cells augments retinal inflammation in a mouse model of diabetes.
    Diabetologia. 2019 Jan 6. pii: 10.1007/s00125-018-4776.
    PubMed     Text format     Abstract available

  45. FARHAT R, Su G, Sejling AS, Knight N, et al
    Carvedilol prevents counterregulatory failure and impaired hypoglycaemia awareness in non-diabetic recurrently hypoglycaemic rats.
    Diabetologia. 2019 Jan 9. pii: 10.1007/s00125-018-4802.
    PubMed     Text format     Abstract available

  46. JENKINS DJA, Kendall CWC, Lamarche B, Banach MS, et al
    Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial.
    Diabetologia. 2019 Jan 8. pii: 10.1007/s00125-018-4795.
    PubMed     Text format     Abstract available

  47. VILLANUEVA-PENACARRILLO ML
    Isabel Valverde, 1937-2018.
    Diabetologia. 2018;61:2251.
    PubMed     Text format    


    Hypertension

  48. KIM MK, Han K, Koh ES, Kim ES, et al
    Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus.
    Hypertension. 2019;73:319-326.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  49. HU J, Hu X, Kan T
    MiR-34c Participates in Diabetic Corneal Neuropathy Via Regulation of Autophagy.
    Invest Ophthalmol Vis Sci. 2019;60:16-25.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  50. ZHONG VW, Juhaeri J, Cole SR, Shay CM, et al
    Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults with Incident Type 2 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 3. pii: 5270382. doi: 10.1210/jc.2018-01402.
    PubMed     Text format     Abstract available

  51. WANG H, Kuang J, Xu M, Gao Z, et al
    Predictors of long-term glycemic remission after 2-week intensive insulin treatment in newly diagnosed type 2 diabetes.
    J Clin Endocrinol Metab. 2019 Jan 9. pii: 5280417. doi: 10.1210/jc.2018-01468.
    PubMed     Text format     Abstract available

  52. WU F, Juonala M, Pahkala K, Buscot MJ, et al
    Youth and long-term dietary calcium intake with risk of impaired glucose metabolism and type 2 diabetes in adulthood.
    J Clin Endocrinol Metab. 2019 Jan 9. pii: 5280418. doi: 10.1210/jc.2018-02321.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  53. LO C, Zimbudzi E, Teede HJ, Kerr PG, et al
    Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease.
    J Diabetes Complications. 2019;33:63-68.
    PubMed     Text format     Abstract available


    J Hypertens

  54. VIAZZI F, Bonino B, Mirijello A, Fioretto P, et al
    Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes.
    J Hypertens. 2019 Jan 7. doi: 10.1097/HJH.0000000000001950.
    PubMed     Text format     Abstract available


    J Nutr

  55. MEKARY RA
    Breakfast Skipping and Type 2 Diabetes: Where Do We Stand?
    J Nutr. 2019 Jan 8. pii: 5280617. doi: 10.1093.
    PubMed     Text format    


    JAMA

  56. SIMHA V, Shah P
    Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.
    JAMA. 2019 Jan 7. pii: 2720429. doi: 10.1001/jama.2018.20922.
    PubMed     Text format    

  57. GRENNAN D
    Diabetic Foot Ulcers.
    JAMA. 2019;321:114.
    PubMed     Text format    


    Lancet

  58. VERMA S, Juni P, Mazer CD
    Pump, pipes, and filter: do SGLT2 inhibitors cover it all?
    Lancet. 2019;393:3-5.
    PubMed     Text format    


    Metabolism

  59. KIM MJ, Kim MN, Min SH, Ham DS, et al
    Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes.
    Metabolism. 2019 Jan 4. pii: S0026-0495(18)30267.
    PubMed     Text format     Abstract available


    Nutr Metab (Lond)

  60. KARUSHEVA Y, Kunstein L, Bierwagen A, Nowotny B, et al
    An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Nutr Metab (Lond). 2018;15:90.
    PubMed     Text format     Abstract available


    Obstet Gynecol

  61. O'MALLEY EG, Turner MJ
    Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
    Obstet Gynecol. 2018;132:1302.
    PubMed     Text format    


    Pediatr Diabetes

  62. JACOBSEN LM, Elding Larsson H, Tamura RN, Vehik K, et al
    Predicting Progression to Type 1 Diabetes from Ages 3 to 6 in Islet Autoantibody Positive TEDDY Children.
    Pediatr Diabetes. 2019 Jan 10. doi: 10.1111/pedi.12812.
    PubMed     Text format     Abstract available


    PLoS One

  63. NIAZI RK, Sun J, Have CT, Hollensted M, et al
    Increased frequency of rare missense PPP1R3B variants among Danish patients with type 2 diabetes.
    PLoS One. 2019;14:e0210114.
    PubMed     Text format     Abstract available

  64. OCANA GJ, Sims EK, Watkins RA, Ragg S, et al
    Analysis of serum Hsp90 as a potential biomarker of beta cell autoimmunity in type 1 diabetes.
    PLoS One. 2019;14:e0208456.
    PubMed     Text format     Abstract available

  65. VALENTINER LS, Thorsen IK, Kongstad MB, Brinklov CF, et al
    Effect of ecological momentary assessment, goal-setting and personalized phone-calls on adherence to interval walking training using the InterWalk application among patients with type 2 diabetes-A pilot randomized controlled trial.
    PLoS One. 2019;14:e0208181.
    PubMed     Text format     Abstract available

  66. COUCHA M, Barrett AC, Elgebaly M, Ergul A, et al
    Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats.
    PLoS One. 2019;14:e0210523.
    PubMed     Text format     Abstract available

  67. BRAFFETT BH, Rice MM, Young HA, Lachin JM, et al
    Mediation of the association of smoking and microvascular complications by glycemic control in type 1 diabetes.
    PLoS One. 2019;14:e0210367.
    PubMed     Text format     Abstract available

  68. CHANG HW, Lin YW, Lin MH, Lan YC, et al
    Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
    PLoS One. 2019;14:e0210085.
    PubMed     Text format     Abstract available

  69. MATIC PETROVIC S, Radunovic M, Barac M, Kuzmanovic Pficer J, et al
    Subgingival areas as potential reservoirs of different Candida spp in type 2 diabetes patients and healthy subjects.
    PLoS One. 2019;14:e0210527.
    PubMed     Text format     Abstract available


    Stroke

  70. SHEN Y, Shi L, Nauman E, Katzmarzyk PT, et al
    Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus.
    Stroke. 2019 Jan 10:STROKEAHA118023682. doi: 10.1161/STROKEAHA.118.023682.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: